Skip to the page

Data / Drug companies / Solupharm Pharmazeutische Erzeugnisse GmbH

Solupharm Pharmazeutische Erzeugnisse GmbH: 10 products in the FDA NDC directory, labeler code 55579

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Solupharm Pharmazeutische Erzeugnisse GmbH (labeler code 55579) lists 10 products in the FDA National Drug Code Directory, covering 4 finished drugs by generic name. By type: 5 drugs for further processing, 5 prescription drugs. Its main marketing category is drugs for further processing. The newest product started marketing on July 28, 2026.

The request: Watch Solupharm Pharmazeutische Erzeugnisse GmbH (FDA labeler code 55579): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
55579
Products in commercial distribution
10
Packages
11
Finished drugs by generic name
4
Prescription products
5
Over the counter products
0
Flagged as original packager
4 of 4 products that carry the flag
Started marketing in the last 12 months
2
Earliest marketing start
April 24, 2008
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Drugs for further processing550%
Generic drugs (ANDA)550%

Products by type

TypeProductsShare
Drugs for further processing550%
Prescription drugs550%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

DrugProductsCompanies listing it
Acetaminophen2214
Alcohol1293
Sugammadex sodium15
Sugammadex122

Dosage forms

Dosage formProductsShare
Injection, solution550%
Liquid330%
Injection220%

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Sugammadex55579-893Injection, solutionGeneric drugs (ANDA)July 28, 2026
Sugammadex55579-892Injection, solutionGeneric drugs (ANDA)July 28, 2026
Dehydrated Alcohol55579-306InjectionGeneric drugs (ANDA)January 8, 2025
Acetaminophen55579-405Injection, solutionGeneric drugs (ANDA)December 7, 2020
Acetaminophen55579-110InjectionGeneric drugs (ANDA)December 7, 2020
Bupivacaine hydrochloride55579-397LiquidDrugs for further processingApril 2, 2019
Lidocaine hydrochloride55579-939LiquidDrugs for further processingAugust 3, 2018
Sodium chloride55579-937LiquidDrugs for further processingAugust 9, 2016
Promethazine hydrochloride55579-402Injection, solutionDrugs for further processingApril 24, 2008
Promethazine hydrochloride55579-401Injection, solutionDrugs for further processingApril 24, 2008

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.